Drug Type Small molecule drug |
Synonyms BG 129, BG-129, BG129 |
Target |
Action inhibitors |
Mechanism ATR inhibitors(Serine-protein kinase ATR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Preclinical | United States | 01 Jul 2019 | |
| Ovarian Cancer | Preclinical | United States | 01 Jul 2019 | |
| Small Cell Lung Cancer | Preclinical | United States | 01 Jul 2019 | |
| Solid tumor | Preclinical | United States | - |





